Vimarsana
Biggest News Aggregation in the World

Page 5 - Restricted Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Restricted Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Restricted Use Today - Breaking & Trending Today

India's drug controller grants approval to 1st intranasal COVID-19 vaccine-Xinhua - Vimarsana News

India's drug controller grants approval to 1st intranasal COVID-19 vaccine-Xinhua

India's drug controller grants approval to 1st intranasal COVID-19 vaccine-

iNCOVACC, world's first nasal Covid-19 vaccine manufactured by Bharat Biotech to receive both primary series and Heterologous booster approval - New Delhi Times - Vimarsana News

iNCOVACC, world's first nasal Covid-19 vaccine manufactured by Bharat Biotech to receive both primary series and Heterologous booster approval - New Delhi Times

Hyderabad based biotechnology company Bharat Biotech has launched the world's first nasal Covid-19 vaccine. According to a Tweet shared by Bharat Biotech, iNCOVACC recently received approval under Restricted Use in Emergency Situation for ages 18 and above for heterologous booster doses According to Bharat Biotech, iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19.…

Drug Regulator Approves Bharat Biotech's Nasal COVID-19 Vaccine; No Data in the Public Domain - Vimarsana News

Drug Regulator Approves Bharat Biotech's Nasal COVID-19 Vaccine; No Data in the Public Domain

The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries, Bharat Biotech said.

Source: thewire.in
World's first intranasal Covid shot by Bharat Biotech cleared as heterologous booster : The Tribune India - Vimarsana News

World's first intranasal Covid shot by Bharat Biotech cleared as heterologous booster : The Tribune India

Makers of the world’s first intranasal Covid 19 shot, Hyderabad-based Bharat Biotech, on Monday announced that the vaccine iNCOVACC (BBV154) had received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages 18 and above, in

World's 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval - Vimarsana News

World's 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval

Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world's first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) ...